Dsm-firmenich Ag · EURONEXT:DSFIR
Dsm-firmenich — Merger or Acquisition (May 2022)
20 slides from Dsm-firmenich's merger presentation, May 31, 2022
Slide 1: Merger of DSM & Firmenich
Merger of DSM & Firmenich The Leading Creation and Innovation Partner in Nutrition, Beauty and Well-Being MAY 31, 2022
Slide 2: Disclaimers
For Internal Use Only Disclaimers NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION in such securities in the United States. WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
Slide 3: Today’s Presenters
Today’s Presenters Geraldine Matchett Dimitri de Vreeze Gilbert Ghostine DSM Co-CEO DSM Co-CEO Firmenich CEO 3
Slide 4: Leadership Across Nutrition, Beauty and Well-Being
For Internal Use Only Leadership Across Nutrition, Beauty and Well-Being An €11bn+ revenue company supported by a superior foundation in science and technology and a world- class vertically integrated supply chain DSM1 Firmenich2 Innovator in Health, Nutrition & Bioscience Creators in Taste and Perf
Slide 5: Introduction to Firmenich
01 Introduction to Firmenich
Slide 6: Firmenich at a Glance
For Internal Use Only Firmenich at a Glance 4.5 Billion CHF 5.0% 20% Revenue Growth CAGR2 Adjusted EBITDA Margin1 Revenues1 9.3% of Revenues Invested Co-Leader in Perfumery & 100+ Ingredients 3 in R&D in 2021 Markets 127 ~10,000 7.5 Years Swiss and colleagues1 Sustainalytics Rating Family-Owned Indu
Slide 7: Leadership Across Business Units
For Internal Use Only Leadership Across Business Units TASTE & BEYOND PERFUMERY & INGREDIENTS ▪ Co-leadership position across Perfumery and ▪ Global player of scale Ingredients segments 33% 67% ▪ Leading innovator in Natural / Clean Label ▪ Leading portfolio of sustainable, renewable, Transformation
Slide 8: Track-Record of Innovation-Driven Growth, Underpinned by World-Class Science
For Internal Use Only Track-Record of Innovation-Driven Growth, Underpinned by World-Class Science 2021 R&D Spend as % of Revenues 9.3% 8.4% 6.1% 5.9% 1939 6 4,000+ Top 100 NOBEL PRIZE R&D CENTERS PATENTS INNOVATOR FOR Geneva IN FORCE Patent Castets Asset Index CHEMISTRY Princeton & San Diego Shangh
Slide 9: ESG at the Core of Firmenich’s Mission and a Source of Competitive Advantage
For Internal Use Only ESG at the Core of Firmenich’s Mission and a Source of Competitive Advantage 37th of nearly 15,000 Top 1% of 85,000+ Recognized by 1 of only 2 companies 1 of 2 companies companies worldwide companies worldwide Ethisphere® as one of worldwide to be triple globally rated and indu
Slide 10: DSM’s Journey
02 DSM’s Journey
Slide 11: Transformation into a Leader in Health, Nutrition & Bioscience
For Internal Use Only Transformation into a Leader in Health, Nutrition & Bioscience More than 150 years of Two decades of Unique business model and Serving highly attractive markets deep scientific heritage successful transformation rich innovation pipeline for people and the planet 1 1902: Royal D
Slide 12: DSM-Firmenich Strategic Vision
03 DSM-Firmenich Strategic Vision
Slide 13: The Leading Creation and Innovation Partner in Nutrition, Beauty and Well-Being
For Internal Use Only The Leading Creation and Innovation Partner in Nutrition, Beauty and Well-Being Health, Nutrition Animal Four high-performing businesses uniquely & Care Nutrition positioned to address consumer trends 19% & Health 29% Food & Unparalleled (bio)science and technology Beverage / p
Slide 14: Four High-Performing and Complementary Businesses
For Internal Use Only Four High-Performing and Complementary Businesses Food & Beverage / Perfumery & Beauty Health, Nutrition & Care Animal Nutrition & Health Taste & Beyond Creators of positive perfumes and Provide delicious, nutritious and sustainable Keeping the world’s growing Transforming anim
Slide 15: Science Leader with Complementary Capabilities
For Internal Use Only Science Leader with Complementary Capabilities Proven Track Record and Established Broadest Science Foundation Continued Commitment to Innovate Innovation Pipeline Data Science & Naturals Microbiology Differentiated Creation Sustainability Wellness €700m+ AI Extraction & microb
Slide 16: Continued Purpose-Led Commitment to People and Planet
For Internal Use Only Continued Purpose-Led Commitment to People and Planet Sustainability as a core value embedded across both organizations' strategies Global recognition World-leading partnerships P:\PresentationCenter\London P - arisMaterials\ Brunello - UN Sustainabili tyWheel\UN Sustainability
Slide 17: DSM-Firmenich Financial & Governance Highlights
04 DSM-Firmenich Financial & Governance Highlights
Slide 18: Robust Financial Profile for Superior Shareholder Value Creation
For Internal Use Only Robust Financial Profile for Superior Shareholder Value Creation Health, ▪ Mid-single-digit organic sales growth to gradually Nutrition Animal Sales accelerate to a 5-7% range, supported by revenue & Care Nutrition Mid-Term synergies and innovation 19% & Health Ambition2 ▪ 20%+
Slide 19: Merger of Equals
For Internal Use Only Merger of Equals Transaction ▪ Merger of equals between DSM and Firmenich through a DSM-Firmenich domiciled in Switzerland Structure ▪ Public offer for DSM shares in exchange for DSM-Firmenich shares ▪ At inception, DSM’s shareholders will own 65.5% of DSM-Firmenich DSM-Firmeni
Slide 20: Creation and Innovation Partner with Market-Leading Capabilities to Better Serve Our Customers
For Internal Use Only Creation and Innovation Partner with Market-Leading Capabilities to Better Serve Our Customers Food & Beverage / Health, Nutrition & Animal Nutrition & Perfumery & Beauty Taste & Beyond Care Health